|Edition Mondiale

S&P 500 7,165 +0.38%NASDAQ 24,837 +0.73%BTC $77,423 -0.28%ETH $2,312 -0.56%SOL $85.84 -1.04%EUR/USD 1.1726 +0.17%GOLD 4,741 +0.76%S&P 500 7,165 +0.38%NASDAQ 24,837 +0.73%BTC $77,423 -0.28%ETH $2,312 -0.56%SOL $85.84 -1.04%EUR/USD 1.1726 +0.17%GOLD 4,741 +0.76%

GlobalMarkets

Today

Finance

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.

CNBC

April 24, 2026·1 min de lecture

Finance

Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump.

Article original

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

Publié par CNBC

Lire l'article complet